Accuray (ARAY) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -52.57% |
| Sep 30, 2025 | -46.38% |
| Mar 31, 2025 | -66.43% |
| Dec 31, 2024 | -4.40% |
| Sep 30, 2024 | 2.44% |
| Mar 31, 2024 | -25.23% |
| Dec 31, 2023 | -15.19% |
| Sep 30, 2023 | 7.38% |
| Mar 31, 2023 | -17.31% |
| Dec 31, 2022 | -9.20% |
| Sep 30, 2022 | -6.49% |
| Mar 31, 2022 | -17.39% |
| Dec 31, 2021 | -94.30% |
| Sep 30, 2021 | -17.98% |
| Mar 31, 2021 | 21.81% |
| Dec 31, 2020 | 24.54% |
| Sep 30, 2020 | 35.21% |
| Jun 30, 2020 | 44.40% |
| Mar 31, 2020 | 31.26% |
| Dec 31, 2019 | 33.59% |
| Sep 30, 2019 | -15.33% |
| Jun 30, 2019 | -17.85% |
| Mar 31, 2019 | -55.59% |
| Dec 31, 2018 | -16.05% |
| Sep 30, 2018 | -1.60% |
| Jun 30, 2018 | 56.92% |
| Mar 31, 2018 | 60.96% |
| Dec 31, 2017 | 23.97% |
| Sep 30, 2017 | 37.07% |
| Jun 30, 2017 | 10.60% |
| Mar 31, 2017 | 42.15% |
| Dec 31, 2016 | 60.20% |
| Sep 30, 2016 | 32.86% |
| Jun 30, 2016 | 6.61% |
| Mar 31, 2016 | -18.35% |
| Dec 31, 2015 | 14.46% |
| Sep 30, 2015 | -23.01% |